updated chart, page-3272

Its a speculative biotech, it's not 100% black and white, but mostly they need announcements, positive announcements, until they drift at the discretion of the market, the market drifts downwards and they head south, however the same doesn't usually apply when the market is in positive territory, because (I think, my opinion and not advice) is that they need to give reasons for SH's to purchase on the chance that, as a speculative biotech, they will provide a return of multiples on their initial outlay, until then the SP will slowly wilt...where is SYC, I am not sure he can do that much in terms of generating positive data, however one would hope he could do lots in terms of establishing meaningful partnerships for our PTX100 product, and without being too critical he was everywhere one year ago, now rarely seen or heard....